Answer
Onglyza (saxagliptin hydrochloride) may have a negligible influence on driving or using machines, but dizziness has been reported and hypoglycaemia risk should be considered when combined with other antidiabetic medicines known to cause hypoglycaemia, such as insulin or sulphonylureas.
Sources for this answer
- Onglyza 5mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 26Document updated
Sources checked